Report Shows Triple Therapy is New Hep C Standard
Six months after Incivek and Victrelis were approved by the FDA for Hepatitis C, a LaunchTrends® report indicates that triple therapy with these drugs is the new standard of care for treating genotype 1 Hepatitis C.
Continue reading »